Cancer Cell International : Impact Factor & More
eISSN: 1475-2867pISSN: 1475-2867
Open AccessShare this on:
Key Metrics
CiteScore 
6.8
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q3Genetics
SNIP
1.07
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Cell International
Cancer Cell International Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2390 | USD 2890 | GBP 2090 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Cancer Cell International ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Cell International
NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor models.
- 7 Aug 2026
- Cancer cell international
Retraction Note: MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene
- 29 Jul 2026
- Cancer Cell International
Quantifying target antigen-dependent CAR T-cell performance against AML
- 29 Jul 2026
- Cancer Cell International
The oral microbiota in oral squamous cell carcinoma: unravelling mechanisms and clinical potential.
- 22 Jul 2026
- Cancer cell international
CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions.
- 20 Jul 2026
- Cancer cell international
Exosomes in cancer drug resistance: dual roles in therapy failure and emerging precision therapeutics.
- 20 Jul 2026
- Cancer cell international
NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor models.
- 7 Aug 2026
- Cancer cell international
Retraction Note: MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene
- 29 Jul 2026
- Cancer Cell International
Quantifying target antigen-dependent CAR T-cell performance against AML
- 29 Jul 2026
- Cancer Cell International
The oral microbiota in oral squamous cell carcinoma: unravelling mechanisms and clinical potential.
- 22 Jul 2026
- Cancer cell international
CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions.
- 20 Jul 2026
- Cancer cell international
Exosomes in cancer drug resistance: dual roles in therapy failure and emerging precision therapeutics.
- 20 Jul 2026
- Cancer cell international
FAQs on Cancer Cell International
How long has Cancer Cell International been actively publishing? 
What is the publishing frequency of Cancer Cell International?
How many articles did Cancer Cell International publish last year?
What is the eISSN & pISSN for Cancer Cell International?
What is Citescore for Cancer Cell International?
What is SNIP score for Cancer Cell International?
What is the SJR for Cancer Cell International?
Who is the publisher of Cancer Cell International?
